| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |